Please provide your email address to receive an email when new articles are posted on . The FDA has approved the first-ever IV iron replacement therapy to improve exercise capacity in adults with ...

(RTTNews) - Viatris (VTRS) announced the FDA has approved Iron Sucrose Injection, USP, an intravenous iron replacement product used to treat iron deficiency anemia in adult and pediatric patients with ...

Panelists discuss how chronic kidney disease leads to iron deficiency anemia through a complex interplay of impaired iron absorption, increased hepcidin production driven by inflammatory cytokines, ...

Please provide your email address to receive an email when new articles are posted on . The FDA approved the first and only IV iron replacement therapy indicated for people with heart failure and iron ...

First and only high-dose intravenous iron for iron deficiency anemia of various etiologies SHIRLEY, N.Y.--(BUSINESS WIRE)--American Regent, Inc., a subsidiary of Luitpold Pharmaceuticals, Inc. (a ...

Objectives Non-anaemic iron deficiency (IDNA) is highly prevalent in exercising females. Although iron therapy can be used to correct this issue, its impact on exercise performance is equivocal. Our ...

Iron therapy may reduce the risk of heart failure hospitalization and cardiovascular death in patients with CKD, according to a meta-analysis of randomized trials. Iron therapy for chronic kidney ...